|
||||||||||||||||||
 |
From: TSS ()
##################### Bovine Spongiform Encephalopathy ##################### Haemophilia: Creutzfeldt-Jakob Disease What is their latest information on the number of patients with haemophilia whose National Health Service treatment could have involved the use of blood from donors now known to have had variant Creutzfeldt-Jakob disease. [HL30] Lord Warner: The United Kingdom Haemophilia Centre Doctors' Organisation is currently collecting information on the number of haemophilia patients considered to be at risk. When this exercise has been completed we will be in a position to provide an estimate on the number of haemophilia patients who have been exposed to plasma products which may be implicated with variant Creutzfeldt-Jakob disease. http://www.publications.parliament.uk/pa/ld199697/ldhansrd/pdvn/lds05/text/50525w01.htm#50525w01_sbhd4 Haemophilia: Recombinant Treatment When they expect recombinant treatment to be available for haemophilia patients throughout England; and to how many such patients it is currently unavailable. [HL29] The Minister of State, Department of Health (Lord Warner): This is the third and final year of the recombinant roll-out programme. All haemophilia patients in England are eligible for treatment with recombinant products in this financial year. Data on the roll-out are collected by the United Kingdom Haemophilia Centre Doctors' Organisation. However, figures are not yet available on the first quarter of this financial year. http://www.publications.parliament.uk/pa/ld199697/ldhansrd/pdvn/lds05/text/50525w01.htm#50525w01_sbhd4 TSS #################### https://lists.aegee.org/bse-l.html ####################
|
